Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of MXN 3.10 trillion. The enterprise value is 4.40 trillion.

Market Cap	3.10T
Enterprise Value	4.40T

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Jan 24, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.42%
Shares Change (QoQ)	+0.16%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.66B

Valuation Ratios

The trailing PE ratio is 37.22.

PE Ratio	37.22
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.75, with an EV/FCF ratio of 27.27.

EV / Earnings	52.77
EV / Sales	3.60
EV / EBITDA	10.75
EV / EBIT	18.21
EV / FCF	27.27

Financial Position

The company has a current ratio of 1.00, with a Debt / Equity ratio of 0.73.

Current Ratio	1.00
Quick Ratio	0.64
Debt / Equity	0.73
Debt / EBITDA	3.46
Debt / FCF	8.26
Interest Coverage	3.78

Financial Efficiency

Return on equity (ROE) is 4.54% and return on invested capital (ROIC) is 4.46%.

Return on Equity (ROE)	4.54%
Return on Assets (ROA)	3.31%
Return on Invested Capital (ROIC)	4.46%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	13.22M
Profits Per Employee	947,041
Employee Count	88,000
Asset Turnover	0.27
Inventory Turnover	1.64

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.33% in the last 52 weeks. The beta is 0.62, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.62
52-Week Price Change	+16.33%
50-Day Moving Average	533.54
200-Day Moving Average	530.65
Relative Strength Index (RSI)	51.75
Average Volume (20 Days)	3,538

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.10

Income Statement

In the last 12 months, Pfizer had revenue of MXN 1.16 trillion and earned 83.34 billion in profits. Earnings per share was 14.59.

Revenue	1.16T
Gross Profit	812.05B
Operating Income	225.28B
Pretax Income	76.52B
Net Income	83.34B
EBITDA	359.98B
EBIT	225.28B
Earnings Per Share (EPS)	14.59

Full Income Statement

Balance Sheet

The company has 195.08 billion in cash and 1.33 trillion in debt, giving a net cash position of -1,136.65 billion.

Cash & Cash Equivalents	195.08B
Total Debt	1.33T
Net Cash	-1,136.65B
Net Cash Per Share	n/a
Equity (Book Value)	1.81T
Book Value Per Share	319.24
Working Capital	235.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 220.76 billion and capital expenditures -59.51 billion, giving a free cash flow of 161.25 billion.

Operating Cash Flow	220.76B
Capital Expenditures	-59.51B
Free Cash Flow	161.25B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.78%, with operating and profit margins of 19.36% and 7.16%.

Gross Margin	69.78%
Operating Margin	19.36%
Pretax Margin	6.58%
Profit Margin	7.16%
EBITDA Margin	30.93%
EBIT Margin	19.36%
FCF Margin	13.86%

Dividends & Yields

This stock pays an annual dividend of 31.96, which amounts to a dividend yield of 5.82%.

Dividend Per Share	31.96
Dividend Yield	5.82%
Dividend Growth (YoY)	12.13%
Years of Dividend Growth	1
Payout Ratio	222.18%
Buyback Yield	0.42%
Shareholder Yield	6.24%
Earnings Yield	2.69%
FCF Yield	5.20%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 1.98. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.98
Piotroski F-Score	n/a